14 Mar 2020

TRUMP, CMS TAKE ACTION TO FIGHT CORONAVIRUS NATIONAL EMERGENCY

  The Trump Administration announced on March 12 aggressive actions and regulatory flexibilities to help healthcare providers and states respond to and contain the spread of 2019 Novel Coronavirus Disease (COVID-19). The Centers for Medicare & Medicaid Services (CMS) is taking these actions following President Trump’s declaration of a national

0
11 Mar 2020

THROMBOLEX INC. BASHIR ENDOVASCULAR CATHETER FIH TRIAL RESULTS REPORTED AT AVF MEETING

    Thrombolex Inc., a medical device company focused on the design, development and manufacture of endovascular therapies for the treatment of arterial and venous thromboembolic disorders, has announced that its First-In-Human (FIH) trial confirms the early safety and feasibility of using the Bashir Endovascular Catheter for pharmaco-mechanical catheter-directed thrombolysis

0
18 Feb 2020

GEOFF MARTHA TO REPLACE OMAR ISHRAK AT MEDTRONIC APRIL 27

       Geoff Martha, who leads Medtronic’s restorative therapies group and previously oversaw the company’s spine business, will succeed Omar Ishrak as president and CEO on April 27. Ishrak ‘s nearly 10-year tenure as chairman and CEO of Medtronic will come to an end when he retires April 26.

0
12 Feb 2020

MEDTRONIC AND THE MEDTRONIC FOUNDATION COMMIT MORE THAN $1M TO CORONAVIRUS EFFORTS

    Medtronic plc  and the Medtronic Foundation are committing approximately $1.2 million to coronavirus relief efforts across the globe. These contributions encompass Medtronic Foundation cash contributions and product donations from the company, according to an announcement Feb. 10.                Medtronic Foundation is partnering

0
12 Feb 2020

THE TYPES OF STAINING THAT MAY OCCUR AFTER SCLEROTHERAPY

  By Peggy Bush There are two types of staining that can occur when treating telangiectasia. Type I is diffuse and results from vessel wall lysis after sclerotherapy. There is red cell extravasation to the reticular dermis and iron pigment remains after red cell lysis. Type II staining occurs with

0
12 Feb 2020

VENOUS SYMPOSIUM 2020: 29 sessions and new aesthetic vein course offered March 18-21

  The Venous Symposium 2020 will convene its 11th annual conference March 19-21 at the Sheraton New York Times Square Hotel, including a Latin language program. VS 2020 has scheduled 29 educational sessions, as well as an aesthetic vein course before the conference begins. In addition, VS also welcomes physicians

0
stack of VTN issues - cropped
20 Jan 2020

VTN ADVERTISING OPPORTUNITY TO BUY OR SELL USED MEDICAL EQUIPMENT

Vein Therapy News has added an economical new advertising opportunity to get rid of  or acquire used medical devices: “Buy or Sell Used Medical Equipment.” Physicians have asked for a forum for moving their older medical equipment that is taking up room in their offices. Publications & Communications Inc., Vein

0
16 Jan 2020

ONE-ON-ONE WITH TRUMP’S MEDICARE AND MEDICAID CHIEF SEEMA VERMA

By Sarah Varney Seema Verma, administrator for the Centers for Medicare & Medicaid Services, sat down for a rare one-on-one interview with Kaiser Health News senior correspondent Sarah Varney. They discussed her views on President Donald Trump’s plan for sustaining public health insurance programs, how the administration would respond if Obamacare

0
09 Jan 2020

REDUCE HEALTH COSTS BY NURTURING THE SICKEST? A MUCH-TOUTED IDEA DISAPPOINTS

  By Dan Gorenstein and Leslie Walker   Improving health and lowering costs for the sickest and most expensive patients in America is a dream harder to realize than many health care leaders had hoped, according to a study published Jan.8 by the New England Journal of Medicine. Researchers tested whether pairing frequently hospitalized

0
19 Dec 2019

FUJIFILM PLANS TO ACQUIRE HITACHI’S MEDICAL IMAGING BUSINESS

  Fujifilm is planning to acquire Hitachi’s medical imaging business in hopes of competing with larger global rivals in the space, according to a Dec. 18 report in Nikkei Asian Review. The purchase of the division could run just north of $1.55 billion, estimates the Review, and is expected to place

0